ORCOSA Inc
Vincent T Mileto has a diverse work experience in the pharmaceutical industry. Vincent T started their career at Sandoz Inc. as a Lead Auditor from January 2005 to April 2006. Vincent T then worked at Cardinal Health as a QA Auditor, Analytical from April 2006 to March 2007. After that, they joined Catalent Pharma Solutions, where they held various roles including Senior Auditor, QA Operations from March 2007 to October 2012, Operations Manager, Advanced Delivery Technologies from October 2012 to February 2016, and Technical Services Leader from February 2016 to July 2016. Vincent T then moved to NewMarket Pharmaceuticals as the Director of Manufacturing and Quality from November 2016 to June 2018. Vincent T subsequently joined Concours Pharmaceuticals as the Vice President & General Manager from July 2018 to March 2021. Currently, they are working at ORCOSA Inc as the Executive Vice President of Operations since November 2020. Throughout their career, they have demonstrated expertise in auditing, quality assurance, manufacturing, and operations management.
Vincent T Mileto completed their education in a chronological order. Vincent T began by attending Ocean County College from 1994 to 1996, where they obtained an A.A. degree in Liberal Arts. Following this, they pursued a higher degree at Monmouth University from 1996 to 1999 and obtained a B.S. degree in Biology and Chemistry. In addition to their formal education, Vincent T Mileto also holds a certification as a Certified Pharmaceutical GMP Professional from the American Society for Quality, although the specific date of obtaining this certification is not provided.
This person is not in any teams
This person is not in any offices
ORCOSA Inc
Orcosa Inc. is a life sciences company modernizing the way medicines are taken and improving patient outcomes through its proprietary therapeutic delivery technology, the Rapid Infusion Technology (RITe™). Founded in 2020, Orcosa is the inventor, developer and exclusive owner of the RITe™ Platform, a fast acting, easy-to-take tablet engineered toenhance drug absorption.